The potential therapeutic applications of RNAi were
realized almost immediately after the phenomenon was first described; over the
years, developers have gradually progressed their proprietary drug candidates
with cautious optimism
Roots Analysis is pleased to announce the publication of its recent
study, titled, “RNAi
Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNA
and DNA.”
The “RNAi Therapeutics Market (2nd Edition), 2019-2030:
Focus On siRNA, miRNA, shRNA and DNA” report features an extensive study of the
current market landscape and future opportunities associated with RNAi
therapeutics. The study also features a detailed analysis of key drivers and
trends within this evolving market. Amongst other elements, the report includes:
To order this 285+ page report, which features 100+ figures
and 110+ tables, please visit this
https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html
§
§
§
§
§
§
§
§
§
- Key
Therapeutic Areas
§
§
§
§
§
§
- Type of RNAi
molecule
§
§
§
§
§
- Route of
administration
§
§
§
§
§
§
- Key geographical
regions
§
§
§
- Leading
Player
To request a sample copy / brochure of this report, please visit
this
Key
companies covered in the report
§
§
§
§
§
§
§
§
§
§
For
more information please click on the following link:
Other Recent Offerings
1.
3.
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical
industry. The in-depth research, analysis and insights are driven by an
experienced leadership team which has gained many years of significant
experience in this sector. If you’d like help with your growing business needs,
get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis